HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $496,600 | +3.8% | 13,000 | -2.0% | 0.00% | 0.0% |
| Q2 2023 | $478,505 | -49.3% | 13,266 | -46.3% | 0.00% | -50.0% |
| Q1 2023 | $943,293 | -28.2% | 24,700 | +6.9% | 0.00% | -50.0% |
| Q4 2022 | $1,314,390 | +174.7% | 23,100 | +74.1% | 0.01% | +700.0% |
| Q2 2022 | $478,505 | +71.5% | 13,266 | +25.2% | 0.00% | 0.0% |
| Q3 2020 | $279,000 | -87.0% | 10,600 | -86.8% | 0.00% | -87.5% |
| Q2 2020 | $2,147,000 | +1054.3% | 80,100 | +662.9% | 0.01% | +700.0% |
| Q4 2019 | $186,000 | +5.1% | 10,500 | -8.0% | 0.00% | 0.0% |
| Q3 2019 | $177,000 | -9.7% | 11,412 | -0.2% | 0.00% | 0.0% |
| Q2 2019 | $196,000 | +4.8% | 11,439 | -1.5% | 0.00% | 0.0% |
| Q1 2019 | $187,000 | +5.6% | 11,616 | -3.7% | 0.00% | 0.0% |
| Q4 2018 | $177,000 | -15.3% | 12,061 | +5.0% | 0.00% | 0.0% |
| Q3 2018 | $209,000 | – | 11,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,506,473 | $61,283,000 | 5.13% |
| First Light Asset Management, LLC | 1,477,496 | $60,105,000 | 3.96% |
| SNYDER CAPITAL MANAGEMENT L P | 3,427,476 | $139,430,000 | 3.69% |
| DOHENY ASSET MANAGEMENT /CA | 80,400 | $3,271,000 | 2.34% |
| Redwood Investments, LLC | 619,766 | $25,212,000 | 2.11% |
| HighMark Wealth Management LLC | 53,341 | $2,170,000 | 1.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 60,170 | $2,448,000 | 1.38% |
| Third Security, LLC | 168,604 | $6,859,000 | 1.33% |
| Taylor Wealth Management Partners | 87,654 | $3,566,000 | 1.27% |
| Penn Capital Management Company, LLC | 290,394 | $11,813,000 | 1.19% |